Exploring the Anticancer Potential of <i>Saussurea costus</i> Phytoconstituents Against Prostate Cancer Using Virtual Screening and Molecular Docking
Background: Cancer remains a leading cause of death globally, necessitating the development of novel and targeted therapies. Natural products derived from traditional medicinal plants, such as Saussurea costus, offer promising anticancer potential due to their bioactive compounds. Virtual screening provides an efficient in silico approach to identify potential drug candidates by targeting specific pathways and molecular mechanisms associated with cancer. Objectives: This study aimed to identify bioactive compounds in S. costus with potential anticancer properties and to elucidate their mechanisms of action using virtual screening, molecular docking, and pathway enrichment analyses. Methods: Compounds from the IMPPAT database were screened for drug-likeness and pharmacokinetics using SwissADME and PASS webserver tools. Toxicity predictions were conducted using ProTox-II. Differentially Expressed Genes (DEGs) associated with prostate cancer were identified through GEO2R analysis of the GSE47108 dataset. Overlapping genes between DEGs and compound targets were subjected to Protein-Protein Interaction (PPI) network analysis using STRING and Cytoscape to identify hub genes. Molecular docking of selected compounds with hub genes was performed using AutoDock Vina, and pathway analysis was conducted using ShinyGO and KEGG databases. Results: Three compounds—stigmasterol, isoboldine, and beta-sitosterol—were identified with favorable ADME and toxicity profiles. Hub genes such as SRC, FGFR1, and HSP90AA1 were strongly associated with prostate cancer pathways. Docking studies revealed significant binding affinities, with stigmasterol showing the strongest interaction with HSP90AA1. Pathway enrichment highlighted the involvement of PI3K/AKT and cancer-related pathways. Conclusion: Saussurea costus exhibits multi-targeted anticancer potential, particularly against prostate cancer. These findings warrant further in vitro and in vivo studies to validate the therapeutic efficacy of